In France, in 2007, 17 000 patients underwent carotid endarterectomy. The risk of having an ipsilateral postoperative stroke after carotid endarterectomy remains at 1-1.5%. There is no consensus concerning the best cerebral monitoring and hemodynamic optimisation during carotid cross-clamping. The objective of this prospective, multicentric, double-blinded and randomized study is to evaluate the interest of continuous cerebral oximetry monitoring by INVOS™ cerebral oximeter to direct the hemodynamic optimisation during carotid endarterectomy and reduce the new-onset of postoperative radiological (MRI) ischemic lesions. A cost/effectiveness analysis will be conducted to estimate the impact of this monitoring versus standard care on direct and indirect postoperative costs during 120 days. A substudy will evaluate the effect of this monitoring on neurocognitive outcome and on a serum marker of brain injury, protein S-100B
After consent, patients will be randomized in two groups: one group with continuous per operative cerebral oximetry monitoring associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline; the second group is continuously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre. All patients have a preoperative and a postoperative diffusion cerebral MRI to detect new onset of cerebral ischemic lesion. The amount and the volume of cerebral ischemic lesions will be scored to compare groups. Quality of life as well as direct (medical and nonmedical) and indirect costs were collected using questionnaires during the 120 postoperative days. A substudy including 200 patients will be conducted to compare the two groups concerning postoperative protein S-100B level and a composite score of neurocognitive tests (measured pre- and postoperatively) The trial will be conducted according to GCP
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Enrollment
879
continuous per operative cerebral oximetry monitoring associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline
the patient is continously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre.
Besancon University Hospital "Hôpital Jean Minjoz"
Besançon, France
Bordeaux University Hospital "Haut Lévêque"
Bordeaux, France
Bordeaux University Hospital "Hôpital Pellegrin"
Bordeaux, France
Brest University Hospital "La Cavale Blanche"
Brest, France
Caen University Hospital "Côte de Nacre"
Caen, France
Dijon University Hospital "Le Bocage"
Dijon, France
Le Mans Hospital
Le Mans, France
Hospital de Marie Lannelongue Plessis Robinson
Le Plessis-Robinson, France
Lyon University Hospital "Hôpital Edouard Herriot"
Lyon, France
Marseille University Hospital "Hôpital de la Timone"
Marseille, France
...and 9 more locations
The number of new cerebral ischemic lesions
The number of new cerebral ischemic lesions observed on postoperative diffusion MRI
Time frame: Up to 3 days post-operative
Incremental cost-effectiveness ratio comparing the group monitored by cerebral oximeter and the standard care group
Time frame: 4 months post-operative
Hospitalization length of stay
Time frame: 4 months post-operative
Percentage of patient with Neurologic and neurocognitive postoperative disorders
* Percentage of patient with Spatiotemporal disorientation * Percentage of patient with aphasia * Percentage of patient with Facial paralysis * Percentage of patient with Limb sensory or motor deficit * Percentage of patient with Seizure * Percentage of patient with Balance disorder
Time frame: 4 months post-operative
Percentage of patient with Cardiovascular postoperative disorders
* Percentage of patient with myocardial infaction * Percentage of patient with atrial fibrillation or atrial flutter * Percentage of patient with acute left ventricle failure * Percentage of patient with Uncontrolled high blood pressure
Time frame: 4 months post-operative
Percentage of patient with Surgical events
* Percentage of patient with surgical site infection * Percentage of patient with haematoma evacuation
Time frame: 4 months post-operative
Postoperative quality of life (SF36, EQ5D tests)
SF36 score for quality of life assessment : * Physical quality score \[Time Frame: Through study completion, 4 month postoperatively\] Items from the SF36 (Short Form 36) survey * Mental quality score \[Time Frame: Through study completion, 4 month postoperatively\] Items from the SF36 (Short Form 36) survey EQ5D3L test for quality of life assessment : * Quality of life evaluated by the EQ 5D 3L questionnaire \[Time Frame: 4 months postoperatively\] * Quality of life, as evaluated by the use EQ 5D 3L auto-questionnaire
Time frame: 4 months post-operative
Incidence of death 4 month postoperatively
Time frame: 4 months post-operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.